Refractory DLBCL: Challenges and Treatment

Elsevier, Clinical Lymphoma, Myeloma and Leukemia, 3(22), p. 140-148, 2022

Journal article published in 2022 by Mendel Goldfinger

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by